The premier European weekly newsletter dedicated to all the financial aspects of Biotechnology has more than 22,000 weekly readers who use it as their invaluable first point of reference because it:
- Provides up-to-date, pertinent information delivered by our experts, investigators and journalists who talk directly to the people who matter;
- Offers efficient networking with professionals through our search engine;
- Helps identify and target potential investors and partners;
- Facilitates exclusive business opportunities, collaboration offers, recruitment, finding investors, acquiring licensing rights, finding equipment and pr...